Insider Transactions Reported by 3 Insiders of Propanc Biopharma, Inc.

Symbol
PPCB on Nasdaq
Location
Camberwell, Victoria, Australia

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Propanc Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Josef Zelinger Director 05 Jul 2023
James Andrew Nathanielsz CEO/CFO, Director 17 Aug 2021
Julian Norman Kenyon Chief Scientific Officer, Director 17 Aug 2021

Recent Insider Transactions by Companies or Individuals for Propanc Biopharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.